Methotrexat medac 25 mg/ml Injektionslösung
Recall
|
Medicines
|
15/11/2024
The marketing authorisation holder informed its customers on November 12, 2024, that visible particles were detected in the mentioned batches during stability tests. To prevent a possible risk to patients, these batches are being recalled as a precautionary measure. Other batches are not affected.
The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.
| Name of the medicinal product | Methotrexat medac 25 mg/ml Injektionslösung |
|---|---|
| Marketing authorisation number(s) | DE-Zulassungsnummer: 80379.00.00 |
| CIP code | DE-PZN: 11180962 |
| Marketing authorisation holder | Medac Gesellschaft für klinische Spezialpräparate m.b.H. |
| Batch number(s) | Batch, Expiry Date N220710A, 30.11.2024 D230403A, 30.04.2025 K230570A, 31.08.2025 K230597AA, 30.09.2025 P230751AA, 30.11.2025 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4987 |
Further inquiry note
Page last modified:
15/11/2024